Management of high-risk breast lesions found on mammogram or ultrasound: the value of contrast-enhanced MRI to exclude malignancy. Clin Imaging 2018;49:174-180
Date
03/24/2018Pubmed ID
29571172DOI
10.1016/j.clinimag.2018.03.011Scopus ID
2-s2.0-85044108709 (requires institutional sign-in at Scopus site) 7 CitationsAbstract
PURPOSE: To evaluate the performance of magnetic resonance imaging (MRI) to exclude malignancy in biopsy-proven high-risk breast lesions prior to surgical excision.
MATERIAL AND METHODS: Breast MRIs performed after a core needle biopsy (CNB) yielding high-risk pathology were evaluated for the presence of suspicious enhancement. The diagnostic performance of MRI to exclude malignancy was calculated.
RESULTS: The average reader sensitivity, specificity, negative predictive value, positive predictive value and accuracy of MRI were 92%, 51%, 98%, 22% and 56%, respectively.
CONCLUSION: Lack of enhancement on MRI at the site of a high-risk lesion was useful for excluding malignancy.
Author List
Hammersley JA, Partridge SC, Blitzer GC, Deitch S, Rahbar HAuthor
Sarah G. Deitch MD Assistant Professor in the Radiology department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
AdultAged
Biopsy
Biopsy, Large-Core Needle
Breast
Breast Neoplasms
Contrast Media
Female
Humans
Magnetic Resonance Imaging
Mammography
Middle Aged
Retrospective Studies
Sensitivity and Specificity
Ultrasonography